Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers.

Murthy SR, Pacak K, Loh YP.

Cell Mol Neurobiol. 2010 Nov;30(8):1377-81. doi: 10.1007/s10571-010-9592-y.

2.

An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.

Lee TK, Murthy SR, Cawley NX, Dhanvantari S, Hewitt SM, Lou H, Lau T, Ma S, Huynh T, Wesley RA, Ng IO, Pacak K, Poon RT, Loh YP.

J Clin Invest. 2011 Mar;121(3):880-92. doi: 10.1172/JCI40433.

3.

Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.

Zhou K, Liang H, Liu Y, Yang C, Liu P, Jiang X.

Tumour Biol. 2013 Dec;34(6):3691-9. doi: 10.1007/s13277-013-0952-3. Epub 2013 Jul 14.

PMID:
23852859
4.

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M, Ghossein RA.

Surgery. 2008 Jun;143(6):759-68. doi: 10.1016/j.surg.2008.02.007. Epub 2008 Apr 14.

PMID:
18549892
5.

The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.

Höring E, Harter PN, Seznec J, Schittenhelm J, Bühring HJ, Bhattacharyya S, von Hattingen E, Zachskorn C, Mittelbronn M, Naumann U.

Acta Neuropathol. 2012 Jul;124(1):83-97. doi: 10.1007/s00401-011-0940-x. Epub 2012 Jan 15.

PMID:
22249620
6.

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer.

Liang XH, Li LL, Wu GG, Xie YC, Zhang GX, Chen W, Yang HF, Liu QL, Li WH, He WG, Huang YN, Zeng XC.

BMC Cancer. 2013 Sep 5;13:412. doi: 10.1186/1471-2407-13-412.

7.

Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer.

Liu A, Shao C, Jin G, Liu R, Hao J, Shao Z, Liu Q, Hu X.

Tumour Biol. 2014 Dec;35(12):12459-65. doi: 10.1007/s13277-014-2564-y. Epub 2014 Nov 6.

PMID:
25374060
8.

Elevated levels of telomerase activity in malignant pheochromocytoma.

Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K.

Cancer. 1998 Jan 1;82(1):176-9.

PMID:
9428495
9.

Differential heparanase-1 expression in malignant and benign pheochromocytomas.

Quiros RM, Kim AW, Maxhimer J, Gattuso P, Xu X, Prinz RA.

J Surg Res. 2002 Nov;108(1):44-50.

PMID:
12443714
10.

Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion.

Murthy SR, Dupart E, Al-Sweel N, Chen A, Cawley NX, Loh YP.

Cancer Lett. 2013 Dec 1;341(2):204-13. doi: 10.1016/j.canlet.2013.08.011. Epub 2013 Aug 11.

12.

Differential regulation and localization of carboxypeptidase D and carboxypeptidase E in human and mouse β-cells.

Chu KY, Briggs MJ, Albrecht T, Drain PF, Johnson JD.

Islets. 2011 Jul-Aug;3(4):155-65. Epub 2011 Jul 1.

PMID:
21628999
13.

Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray.

He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, Harris CC.

Hum Pathol. 2004 Oct;35(10):1196-209.

PMID:
15492986
14.

Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.

Sadow PM, Rumilla KM, Erickson LA, Lloyd RV.

Endocr Pathol. 2008 Summer;19(2):97-103. doi: 10.1007/s12022-008-9028-0.

PMID:
18461287
15.

Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.

Guillemot J, Thouënnon E, Guérin M, Vallet-Erdtmann V, Ravni A, Montéro-Hadjadje M, Lefebvre H, Klein M, Muresan M, Seidah NG, Anouar Y, Yon L.

J Mol Endocrinol. 2012 Feb 6;48(2):115-27. doi: 10.1530/JME-11-0077. Print 2012 Apr.

16.

[Pheochromocytoma--pathohistologic and immunohistochemical aspects].

Tatić S, Havelka M, Paunović I, Bozić V, Diklic A, Brasanac D, Janković R, Jancić-Zguricas M.

Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:7-13. Serbian.

PMID:
12584991
17.

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.

Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.

Thyroid. 2011 Sep;21(9):975-85. doi: 10.1089/thy.2010.0190. Epub 2011 Aug 11.

PMID:
21834681
18.

Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells.

Ohta S, Lai EW, Morris JC, Pang AL, Watanabe M, Yazawa H, Zhang R, Green JE, Chan WY, Sirajuddin P, Taniguchi S, Powers JF, Tischler AS, Pacak K.

Mol Carcinog. 2008 Apr;47(4):245-51.

PMID:
17957724
19.

Adrenergic differentiation and Ret expression in rat pheochromocytomas.

Powers JF, Picard KL, Nyska A, Tischler AS.

Endocr Pathol. 2008 Spring;19(1):9-16. doi: 10.1007/s12022-008-9019-1.

PMID:
18317952
20.

p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.

Sekiya T, Bronstein MD, Benfini K, Longuini VC, Jallad RS, Machado MC, Goncalves TD, Osaki LH, Higashi L, Viana-Jr J, Kater C, Lee M, Molatore S, Francisco G, Chammas R, Naslavsky MS, Schlesinger D, Gama P, Duarte YA, Lebrão ML, Zatz M, Meirelles O, Liberman B, Fragoso MC, Toledo SP, Pellegata NS, Toledo RA.

Endocr Relat Cancer. 2014 Apr 28;21(3):395-404. doi: 10.1530/ERC-13-0486. Print 2014 Jun.

Items per page

Supplemental Content

Write to the Help Desk